Funder: American Heart Association
Due Dates: January 19, 2026 (Letter of Intent) | March 23, 2026 (Full Application, by invitation)
Funding Amounts: Up to $300,000 per award (including 10% indirect costs) over 2 years; up to 5 awards; optional AWS cloud credits up to $30,000 for data analysis.
Summary: Funds research on the effects of GLP-1/GIP agonists in individuals with cardiovascular, kidney, and metabolic disease or obesity, emphasizing population health, treatment variation, and advanced analytics.
Key Information: Letter of Intent required; project lead must be an AHA professional member at a U.S.-based academic or nonprofit institution.